Tesis
Implementación de un Nuevo Método para la Identificación y Control de PRM en Pacientes Internados con Nefropatía del Hospital del IESS de Riobamba
Fecha
2011-06-09Registro en:
Reino Choto, Fanny Isabel. (2011). Implementación de un Nuevo Método para la Identificación y Control de PRM en Pacientes Internados con Nefropatía del Hospital del IESS de Riobamba. Escuela Superior Politécnica de Chimborazo. Riobamba.
Autor
Reino Choto, Fanny Isabel
Resumen
A new method for the identification and control of Medication Related Problems (DRP) was implemented at the Hospital of the Ecuadorian Institute of Social Security (IESS) Riobamba, the purpose of this research was to minimize DRP in hospitalized patients with nephropathy. The new method consisted of the combination of two techniques already studied: Single Dose and Pharmaceutical Care (DADER Method), applied to polymedicated patients with nephropathy, between 30 and 85 years of age. The process begins with: upon admission, review of the patient's medical history to determine the reason for hospitalization and review of the prescribed medication; then a visit to the patient to complete the pharmacotherapeutic profile data and explain the procedure; information was taken from the visits of the treating physician; once the medical visit was concluded, another interview was conducted with each patient. For the rapid and effective identification of DRPs, they were classified according to the Second Granada Consensus of 2002. From the whole process it was determined that: 87% of the patients presented some type of DRP, 62% presented DRP5 (Health problems as a consequence of a non-quantitative insecurity of a medication); 43% presented DRP6 (Receiving a medication that causes an adverse reaction); 37% showed DRP3 (Non-quantitative ineffectiveness of the medication) and 23% DRP4 (Health problem as a consequence of a quantitative ineffectiveness of the medication). After the ADEVA statistical treatment and the t-Students, the application of this new method in hospitalized patients suffering from any type of nephropathy is totally feasible since the patients presented improvement, since an increase in creatinine clearance was achieved, due to a 78% decrease in DRP. This study is capable of promoting numerous benefits for both the patient and the pharmacist, because through this practice improvement is achieved.